HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Wedzicha, J.A. Articles by Muir, J-F. Search for Related Content PubMed PubMed Citation Articles by Wedzicha, J.A. Articles by Muir, J-F.

Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis

¹ St Bartholomew's Hospital, London, UK. ² University Hospital, Rouen, France

CORRESPONDENCE: J.A. Wedzicha, Academic Respiratory Medicine, Dominion House, St Bartholomew's Hospital, London, EC1A 7BE, UK. Fax: 44 2076018616. E-mail: J.A.Wedzicha@qmul.ac.uk

Keywords: Bronchiectasis, chronic obstructive pulmonary disease, cystic fibrosis, nocturnal hypoventilation, noninvasive ventilation

Received: June 5, 2001
Accepted January 14, 2002

Abstract

Although long-term oxygen therapy (LTOT) improves survival, it has little effect on hypoventilation and other outcomes in patients with hypercapnic respiratory failure due to chronic obstructive pulmonary disease (COPD).

Recent studies have shown that the use of noninvasive positive-pressure ventilation, when used in combination with LTOT in selected stable COPD patients, controls hypoventilation and improves daytime arterial blood gases, sleep quality, health status and may have a benefit in reducing exacerbation frequency and severity. Patients who show the greatest reduction in overnight carbon dioxide tension in arterial blood with ventilation are most likely to benefit from long-term ventilatory support.

Some benefits have also been shown in patients with chronic respiratory failure due to bronchiectasis and cystic fibrosis, though survival is inferior in this patient group.

As most studies of noninvasive positive-pressure ventilation in chronic obstructive pulmonary disease have been relatively short term, large multicentre studies with survival, exacerbations and hospital admissions as the primary end points are required to evaluate longer term effects.

This article has been cited by other articles:

				A B Chang and D Bilton Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis Thorax, March 1, 2008; 63(3): 269 - 276. [Abstract] [Full Text] [PDF]

				P. Leger and G. Laier-Groeneveld Infrastructure, funding and follow-up in a programme of noninvasive ventilation Eur. Respir. J., December 1, 2002; 20(6): 1573 - 1578. [Abstract] [Full Text] [PDF]